Servier Ventures
servier.com Direct investor
Servier Ventures is the strategic venture capital fund of the pharmaceutical group Servier, launched in January 2026. It made its first investment in Cytospire Therapeutics in May 2026.
Servier Ventures is a corporate venture arm. It invests directly in companies.
- Layer
- Direct investor
- Stage
- Not stated
Where this comes from
Every fact above was read from a page Servier Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://servier.com/name, is_investor, layer, type, description, status
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 8501 · added 2026-09-29 · link last verified 2026-09-29 · confidence medium
Similar investors
- Accenture VenturesCorporate venture · United States
- Ad4VenturesCorporate venture · Seed – Growth · Cologno Monzese, Italy
- ADB VenturesCorporate venture · Seed – Series A · Manila, Philippines
- Adobe Fund for DesignCorporate venture
- Aflac Ventures Japan K.K.Corporate venture · Tokyo, Japan
- Agnition VenturesCorporate venture · Christchurch, New Zealand